Analysts predict high and low EPS estimates for Vaxxinity Inc (VAXX)

In the latest session, Vaxxinity Inc (NASDAQ: VAXX) closed at $0.72 up 4.14% from its previous closing price of $0.69. In other words, the price has increased by $+0.0285 from its previous closing price. On the day, 339473 shares were traded. VAXX stock price reached its highest trading level at $0.7300 during the session, while it also had its lowest trading level at $0.6700.

Ratios:

For a deeper understanding of Vaxxinity Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.89 and its Current Ratio is at 1.89. In the meantime, Its Debt-to-Equity ratio is 1.13 whereas as Long-Term Debt/Eq ratio is at 0.99.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Robert W. Baird on September 08, 2023, initiated with a Outperform rating and assigned the stock a target price of $7.

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Sep 08 ’23 when Prime Movers Lab Fund I LP sold 25,089 shares for $1.67 per share. The transaction valued at 41,899 led to the insider holds 8,713,663 shares of the business.

Prime Movers Lab Fund I LP sold 22,872 shares of VAXX for $38,196 on Sep 08 ’23. The 10% Owner now owns 831,658 shares after completing the transaction at $1.67 per share. On Sep 07 ’23, another insider, Prime Movers Lab Fund I LP, who serves as the 10% Owner of the company, sold 20,312 shares for $1.79 each. As a result, the insider received 36,302 and left with 8,738,752 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VAXX now has a Market Capitalization of 86.82M and an Enterprise Value of 57.61M. Its current Enterprise Value per Revenue stands at -199.98k whereas that against EBITDA is -0.92.

Stock Price History:

Over the past 52 weeks, VAXX has reached a high of $3.10, while it has fallen to a 52-week low of $0.56. The 50-Day Moving Average of the stock is 0.7132, while the 200-Day Moving Average is calculated to be 1.3675.

Shares Statistics:

For the past three months, VAXX has traded an average of 410.78K shares per day and 251.71k over the past ten days. A total of 112.87M shares are outstanding, with a floating share count of 45.31M. Insiders hold about 64.25% of the company’s shares, while institutions hold 9.95% stake in the company. Shares short for VAXX as of Mar 15, 2024 were 3.85M with a Short Ratio of 9.38, compared to 3.81M on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 3.04% and a Short% of Float of 9.00%.

Most Popular

[the_ad id="945"]